Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2024. First Quarter Financial Highlights: First quarter 2024 revenue of $441.7 million, up 23.3%, or 22.8% in constant currency , compared to $358.1 million in the prior year, exceeds the guidance range of 17% to 20% in constant currency due to revenue outperformance for all product lines Total Omnipod revenue of $433.0 million, an increase of 21.1%, or 20.5% in constant currency U.S. Omnipod revenue of $317.7 million, an increase of 22.7% International Omnipod revenue of $115.3 million, an increase of 16.9%, or 14.8% in constant currency Drug Delivery revenue of $8.7 million Gross margin of 69.5%, up 230 basis points, compared to gross margin of 67.2% in the prior year and up 460 basis points compared to adjusted gross margin of 64.9% in the prior year, which excludes income of $8.0 million as
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Dexcom launches upgraded ONE+ device in UK [Yahoo! Finance]Yahoo! Finance
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes [Yahoo! Finance]Yahoo! Finance
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 DiabetesBusiness Wire
- Will DexCom Offer Better Returns Than 3M Stock? [Forbes]Forbes
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 5/16/24 - Form 4
- 5/15/24 - Form 144
- 5/2/24 - Form 4
- DXCM's page on the SEC website